- J&J capitalizes on Nanobiotix cash crunch to capture late-phase cancer candidate for $30M upfront FierceBiotech
- NANOBIOTIX Announces License Agreement for Worldwide Co-development and Commercialization of Potential First-In-Class Radioenhancer NBTXR3 Yahoo Finance
- Nanobiotix ADRs Jump Over 50% After Agreement With J&J’s Janssen Pharmaceutical Investopedia
- Nanobiotix’s stock soars after entering licensing, development deal with J&J’s Janssen Pharmaceutica MarketWatch
- Nanobiotix, NanoString Technologies And Other Big Stocks Moving Higher In Monday’s Pre-Market Session – B Benzinga
- View Full Coverage on Google News
Read original article here